These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15578922)

  • 1. Surface antigens/receptors for targeted cancer treatment: the GnRH receptor/binding site for targeted adenocarcinoma therapy.
    Eaveri R; Ben-Yehudah A; Lorberboum-Galski H
    Curr Cancer Drug Targets; 2004 Dec; 4(8):673-87. PubMed ID: 15578922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted cancer therapy with gonadotropin-releasing hormone chimeric proteins.
    Ben-Yehudah A; Lorberboum-Galski H
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):151-61. PubMed ID: 14748665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH-Bik/Bax/Bak chimeric proteins target and kill adenocarcinoma cells; the general use of pro-apoptotic proteins of the Bcl-2 family as novel killing components of targeting chimeric proteins.
    Azar Y; Lorberboum-Galski H
    Apoptosis; 2000 Dec; 5(6):531-42. PubMed ID: 11303912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilizing a GnRH-based chimeric protein for the detection of adenocarcinoma.
    Lichtenstein M; Ben-Yehudah A; Belostotsky R; Eaveri R; Sabag O; Grodzovski I; Lorberboum-Galski H
    Int J Oncol; 2005 Jul; 27(1):143-8. PubMed ID: 15942653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and characterization of a recombinant immunotoxin for targeted therapy of breast cancer cells: In vitro and in silico analyses.
    Barazesh M; Mohammadi S; Jalili S; Kavousipour S; Faraji SN; Mokarram P; Pirhadi S
    Life Sci; 2021 Jan; 265():118866. PubMed ID: 33301810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GnRH receptor and apoptotic signaling.
    Imai A; Tamaya T
    Vitam Horm; 2000; 59():1-33. PubMed ID: 10714235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma cells are targeted by the new GnRH-PE66 chimeric toxin through specific gonadotropin-releasing hormone binding sites.
    Nechushtan A; Yarkoni S; Marianovsky I; Lorberboum-Galski H
    J Biol Chem; 1997 Apr; 272(17):11597-603. PubMed ID: 9111076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.
    Engel J; Emons G; Pinski J; Schally AV
    Expert Opin Investig Drugs; 2012 Jun; 21(6):891-9. PubMed ID: 22577891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using apoptosis for targeted cancer therapy by a new gonadotropin releasing hormone-DNA fragmentation factor 40 chimeric protein.
    Ben-Yehudah A; Aqeilan R; Robashkevich D; Lorberboum-Galski H
    Clin Cancer Res; 2003 Mar; 9(3):1179-90. PubMed ID: 12631624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding and cytotoxicity of conjugated and recombinant fusion proteins targeted to the gonadotropin-releasing hormone receptor.
    Qi L; Nett TM; Allen MC; Sha X; Harrison GS; Frederick BA; Crawford ED; Glode LM
    Cancer Res; 2004 Mar; 64(6):2090-5. PubMed ID: 15026348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients?
    Montagnani Marelli M; Moretti RM; Januszkiewicz-Caulier J; Motta M; Limonta P
    Curr Cancer Drug Targets; 2006 May; 6(3):257-69. PubMed ID: 16712461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective targeted chemotherapy using AEZS-108 (AN-152) for LHRH receptor-positive pancreatic cancers.
    Gründker C; Ernst J; Reutter MD; Ghadimi BM; Emons G
    Oncol Rep; 2011 Sep; 26(3):629-35. PubMed ID: 21667032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
    Fister S; Günthert AR; Emons G; Gründker C
    Cancer Res; 2007 Feb; 67(4):1750-6. PubMed ID: 17308117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linker-based GnRH-PE chimeric proteins inhibit cancer growth in nude mice.
    Ben-Yehudah A; Yarkoni S; Nechushtan A; Belostotsky R; Lorberboum-Galski H
    Med Oncol; 1999 Apr; 16(1):38-45. PubMed ID: 10382941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
    Fister S; Günthert AR; Aicher B; Paulini KW; Emons G; Gründker C
    Cancer Res; 2009 Aug; 69(16):6473-81. PubMed ID: 19638591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic activity of gonadotropin-releasing hormone (GnRH)-pokeweed antiviral protein conjugates in cell lines expressing GnRH receptors.
    Yang WH; Wieczorck M; Allen MC; Nett TM
    Endocrinology; 2003 Apr; 144(4):1456-63. PubMed ID: 12639929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone and its receptor in normal and malignant cells.
    Harrison GS; Wierman ME; Nett TM; Glode LM
    Endocr Relat Cancer; 2004 Dec; 11(4):725-48. PubMed ID: 15613448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of tumor cells in vitro by using monoclonal antibodies against gonadotropin-releasing hormone receptor.
    Lee G; Ge B
    Cancer Immunol Immunother; 2010 Jul; 59(7):1011-9. PubMed ID: 20182875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway.
    Kim KY; Choi KC; Auersperg N; Leung PC
    Endocr Relat Cancer; 2006 Mar; 13(1):211-20. PubMed ID: 16601289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
    Fister S; Schlotawa L; Günthert AR; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.